Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections.

The clinical efficacy of oral pyronaridine was assessed in 22 symptomatic Cameroonian patients infected with Plasmodium ovale or Plasmodium malariae. All patients were cured on or before day 4. In vitro drug assays confirmed the sensitivity of P. ovale and P. malariae isolates to chloroquine and pyr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Ringwald, P, Bickii, J, Same-Ekobo, A, Basco, L K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164120/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9333075/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.10.2317
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!